Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The study will be a non-randomized, open label, single dose, single blind, placebo control,
single center, single arm study in Type I diabetes patients. The study will include single
dose administration for the evaluation of single dose acute toxicity, pharmacokinetics and
activity.